Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haemostatic changes in pregnancy.

Benjamin Brenner1

  • 1Thrombosis and Hemostasis Unit, Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, P.O. Box 9602, Haifa 31096, Israel. b_brenner@rambam.health.gov.il

Thrombosis Research
|October 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer Site.

JACC. CardioOncology·2026
Same author

Peripartum Vascular Calamities: Placental Abruption and Amniotic Fluid Emboli.

Seminars in thrombosis and hemostasis·2026
Same author

Outcomes and predictors of complications after distal deep vein thrombosis: a prospective analysis of 8488 patients.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Maximizing photon utilization in spectroscopic single-molecule localization microscopy using symmetrically dispersed dual-wedge prisms.

Npj imaging·2026
Same author

Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS Onset.

European journal of haematology·2026
Same author

Challenges in Balancing Hemostasis and Thrombosis in Therapy Tailoring for Hemophilia: A Narrative Review.

International journal of molecular sciences·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
Same journal

Molecular basis of the E69Q and R383W heterozygous F2 variants identified in the proband associated with severe hemostatic defects.

Thrombosis research·2026
See all related articles

Pregnancy significantly elevates blood clotting factors and reduces anticoagulants, increasing thrombotic risk. These hemostatic changes normalize postpartum, but disruptions can cause pregnancy complications.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Reproductive Biology

Background:

  • Pregnancy involves significant hemostatic changes, increasing coagulant factors and decreasing natural anticoagulants.
  • Fibrinolytic activity is suppressed by placental plasminogen activator inhibitor type 2 (PAI-2).
  • Elevated D-dimer levels reflect increased fibrinolysis during gestation.

Purpose of the Study:

  • To detail the procoagulant and anticoagulant alterations during normal pregnancy.
  • To elucidate the role of local placental hemostasis in pregnancy.
  • To explore the implications of disrupted anticoagulation in pregnancy complications.

Main Methods:

  • Review of hemostatic markers including coagulation factors, prothrombin fragments, and anticoagulant proteins.

Related Experiment Videos

  • Assessment of fibrinolytic activity and its inhibitors, such as PAI-2.
  • Examination of local placental hemostasis and the impact of antiphospholipid antibodies.

    • Main Results:

    • Maternal blood shows increased levels of factors VII, X, VIII, fibrinogen, and von Willebrand factor.
    • Reduced protein S activity and acquired activated protein C resistance are observed.
    • Increased thrombotic risk (4- to 10-fold) is noted throughout pregnancy and postpartum.

    Conclusions:

    • Pregnancy-induced hemostatic changes create a prothrombotic state.
    • Impaired fibrinolysis due to PAI-2 and local placental factors contribute to this state.
    • Disruptions in anticoagulant mechanisms, like those seen in antiphospholipid antibody syndrome, can lead to adverse pregnancy outcomes.